Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Depressive Disorder and CYP2C9[original query]
CYP2C9 gene and susceptibility to major depressive disorder.
The pharmacogenomics journal 2003 3 (5): 300-2.
LLerena A, Berecz R, Dorado P, González A P, Peñas-LLedó E M, De La Rubia
Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital.
Personalized medicine 2008 Nov 5 (6): 579-587.
Ruaño Gualberto, Villagra David, Rahim Umme Salma, Windemuth Andreas, Kocherla Mohan, Bower Bruce, Szarek Bonnie L, Goethe John
Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.
Biomarkers in medicine 2011 Aug 5 (4): 439-49.
Ruaño Gualberto, Villagra David, Szarek Bonnie, Windemuth Andreas, Kocherla Mohan, Gorowski Krystyna, Berrezueta Christopher, Schwartz Harold I, Goethe Jo
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
European archives of psychiatry and clinical neuroscience 2012 Oct .
Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S
Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.
The pharmacogenomics journal 2018 5 18 (5): 613-622.
Bousman Chad A, Dunlop Boadie
Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.
Clinical pharmacology and therapeutics 2019 10 107 (3): 662-670.
Qin Sisi, Eugene Andy R, Liu Duan, Zhang Lingxin, Neavin Drew, Biernacka Joanna M, Yu Jia, Weinshilboum Richard M, Wang Liew
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population.
Pharmacopsychiatry 2020 Dec .
Hahn Martina, Müller Daniel J, Roll Sibylle
Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Psychopharmacology bulletin 2021 6 51 (2): 31-42.
Zastrozhin M S, Skryabin VYu, Smirnov VYu, Zastrozhina A K, Kaverina E V, Klepikov D A, Grishina E A, Ryzhikova K A, Bure I V, Bryun E A, Sychev D
Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.
Psychopharmacology bulletin 2021 4 51 (1): 69-80.
Zastrozhin M S, Skryabin VYu, Smirnov VYu, Zastrozhina A K, Kaverina E V, Klepikov D A, Grishina E A, Ryzhikova K A, Bure I V, Bryun E A, Sychev D
TOP